Tissue Free Drug Concentrations
Wednesday April 25, 2018
8:30 am
-
11:00 am
Eastern Time (ET)
Room 15B
DCP
DMDD
Chair :
Donglu Zhang
Genentech
Julie Lade
Amgen
Under thermodynamic conditions, the free drug concentration in tissues should equal to that in circulation. However, drug disposition factors such as antigen‐/drug transporters‐mediated uptake, and other common properties such as tissue accumulation and covalent binding kinetically alter drug forms and concentrations in tissues. In turn, the actual drug free concentrations in tissues instead of that in circulation determine efficacy and toxicity of a drug. This session will focus on examples to support the importance of tissue concentration of a drug or metabolites that is a critical parameter but often missing in drug discovery and development.
Speakers
Donglu Zhang
- Genentech
Exceptions to Free Drug Assumption
Jashvant Unadkat
- University of Washington
Pursuing the Holy Grail of Predicting and Verifying Tissue Drug Concentrations: A Proteomics and PET-imaging Approach
Lijuan Jiang
- Enanta Pharmaceuticals
Target Tissue Drug Concentrations are Critical for the Efficacy of Antibiotics and Anti-viral Drugs
Julie Lade
- Amgen
Pharmacokinetics, Metabolism, and Biodistribution of a Liver-targeted siRNA Therapeutic
Sheerin Shahidi-Latham
- Genentech
High-Resolution Imaging MALDI Mass Spectrometry to Assess Label-Free Drug Disposition in Tissues
Herana Seneviratne
- Johns Hopkins University School of Medicine
MALDI Mass Spectrometry Imaging Reveals Heterogenous Distribution of Tenofovir and Tenofovir-Diphosphate in Human Colorectal Tissue
Gautham Gampa
- University of Minnesota
Delivery of Active Drug Concentrations to Brain Tumor Targets